Cardioxane--ICRF-187 towards anticancer drug specificity through selective toxicity reduction

Cancer Treat Rev. 1991 Mar;18(1):1-19. doi: 10.1016/0305-7372(91)90002-h.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects*
  • Heart / drug effects*
  • Humans
  • Razoxane / pharmacology*

Substances

  • Antineoplastic Agents
  • Razoxane